ABOUT US

Drug Discovery and Development Consultants was founded in 2018 with the objective of addressing a need in the market through offering a consultancy service providing support and advice across all aspects of drug discovery and development. As a team, we benefit from the advantage of having worked together for many years thus providing obvious efficiencies in ensuring cost-effective and timely delivery of our client’s objectives. We also benefit from access to an extended network of both industry and academia-based associates as befits our longevity in the industry. Our collective experience includes:


  • Discovery and implementation of new technologies

  • Drug target identification

  • Drug discovery activities through hit ID, LG, LO and drug candidate nomination

  • Non-clinical development campaigns including pharmacology, drug metabolism and pharmacokinetics (DMPK), drug candidate scale-up, CMC, exploratory and GLP tox

  • Programme leadership/management/budget preparation/project planning

  • Executing programmes as a virtual team from discovery to Phase 1 first time in human and Phase 2 POC

  • Clinical Operations expertise in Phase 1 clinical studies including First in Human and Phase 2 POC

  • Establishing and maintaining Quality Management Systems

  • Regulatory and QA advice

  • In-licensing and out-licensing activities including due diligence on companies as well as assets

  • Working in partnerships with big pharma, biotechs and CROs

  • Company start-ups and sales

 

THE TEAM

 

DR MARTYN PRITCHARD


Director

Discovery and Development Chemistry

DR ISABEL GONZALEZ


Director

Discovery Biology

DR STEPHEN BURBIDGE


Director

Discovery and Preclinical Projects

MIKE HIGGINBOTTOM


Director

Medicinal Chemistry and CMC

ASSOCIATES

 

DR TIM SPAREY

Business Development

DR MAEVE DUFFY

Clinical Development

DR WILLIAM PULLMAN

Translational Medicine (Clinical Development and Regulatory Strategy)

DR BRUCE CAMPBELL

DMPK, safety pharmacology, non-clinical and clinical development

DR PETER VAN ESS

Translational Medicine (Clinical Pharmacology and Clinical Development)

DR SUE SNAPE

Clinical Development

BRADLEY HARDIMAN

Commercialisation, licensing

DR JOANNA SEGIETH

Clinical Development, Rare Diseases

ALLISON MORGAN

Clinical Development

HILARY DONE

Clinical Operations

©2019 DRUG DISCOVERY AND DEVELOPMENT CONSULTANTS LTD. TRADING AS 3D CONSULTANTS. REGISTERED IN ENGLAND AND WALES, COMPANY NUMBER 11438683